CDNA

Latest SEC Filings & News for CDNA

3 most recent filings and news items mentioning CDNA. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/CDNA/news?limit=20"

Pull CDNA filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

CareDx reports Q2 2026 revenue of $132M, raises full-year 2026 guidance to $490-500M

Second quarter 2026 revenue increased 52% year-over-year to $132 million. The company raised its 2026 revenue guidance to $490M-$500M and AEBITDA guidance to $66M-$78M. The growth was driven by strong testing services volume and revenue expansion.

View filing at SEC.gov →

CareDx Completes Sale of Lab Products Business to Eurobio Scientific

CareDx closed the sale of its Lab Products business to Eurobio Scientific for $171.2 million. This divestiture sharpens the company's focus on its core U.S. precision medicine services and operating model.

View filing at SEC.gov →

CareDx increases equity plan share reserve to 6.7 million shares

CareDx's board approved Amendment No. 2 to its 2024 Equity Incentive Plan, increasing the share reserve available for awards to 6.7 million shares, pending stockholder approval. This expansion allows the company greater flexibility in compensating employees and executives through

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.